As a long time shareholder I'm extremely dissappointed in Mr Weldon's performance and the board should change the current compensation program if this is the outcome for the shareholders. I'm all for pay for performance. We have had virtually no stock appreciation under both this board and the current management team for a TEN year period,truly subpar outcome / performance. Time to change all the Board of Directors positions and get this great company back on track. Buffett might be right to reduce share position till management get this company fixed.......Over 140 million in CEO compesation and a salary raise in 2011 for recalls, lawsuits and lost marketshare!!!! Board must be very weak group of individuals but have the authority to pay themselves and CEO very well. Start firing people at the top instead of doing layoffs and cost cutting initiatives to make the financial numbers for Wall Street to earn their bonuses and stock options!!
As a 10 year shareholder with just over 1000 shares, I am very disappointed with Weldon's retirement package. The dismal stock perfomance, the numerous recalls, and lackluster drug development spells failure for this man.
He should have received nothing. He already was being paid quite handsomely.